High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.9M
$4,858,550
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Paolini John F.
• Officer • CHIEF MEDICAL OFFICER
Other
2026-03-02
$414,400
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF MEDICAL OFFICER
Other
|
2026-03-02 | $414,400 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Paolini John F.
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2026-03-02
$1,792,940Largex3
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2026-03-02 | $1,792,940Largex3 | S | Form 4 |
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Paolini John F.
• Officer • CHIEF MEDICAL OFFICER
Other
2025-10-31
$545,040x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF MEDICAL OFFICER
Other
|
2025-10-31 | $545,040x2 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Paolini John F.
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -57.4%
2025-10-31
$3,065,610Large
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -57.4%
|
2025-10-31 | $3,065,610Large | S | Form 4 |